BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17306505)

  • 1. Brain derived neurotropic factor in first-episode psychosis.
    Buckley PF; Pillai A; Evans D; Stirewalt E; Mahadik S
    Schizophr Res; 2007 Mar; 91(1-3):1-5. PubMed ID: 17306505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis.
    Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Aktaş H
    J Clin Psychopharmacol; 2015 Oct; 35(5):596-9. PubMed ID: 26267416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.
    Chen DC; Wang J; Wang B; Yang SC; Zhang CX; Zheng YL; Li YL; Wang N; Yang KB; Xiu MH; Kosten TR; Zhang XY
    Psychopharmacology (Berl); 2009 Dec; 207(3):375-80. PubMed ID: 19787338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.
    Jindal RD; Pillai AK; Mahadik SP; Eklund K; Montrose DM; Keshavan MS
    Schizophr Res; 2010 Jun; 119(1-3):47-51. PubMed ID: 20096541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients.
    Heitz U; Papmeyer M; Studerus E; Egloff L; Ittig S; Andreou C; Vogel T; Borgwardt S; Graf M; Eckert A; Riecher-Rössler A
    World J Biol Psychiatry; 2019 Sep; 20(7):545-554. PubMed ID: 29938562
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain derived Neurotropic Factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis.
    Theleritis C; Fisher HL; Shäfer I; Winters L; Stahl D; Morgan C; Dazzan P; Breedvelt J; Sambath I; Vitoratou S; Russo M; Reichenberg A; Falcone MA; Mondelli V; O'Connor J; David A; McGuire P; Pariante C; Di Forti M; Murray RM; Bonaccorso S
    Schizophr Res; 2014 Oct; 159(1):56-61. PubMed ID: 25171858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor levels and psychopathology scores in drug-naïve first-episode psychosis.
    Aydın MS; Bolu A; Kılınçkaya MF; Öznur T; Çelik C; Uzun Ö; Özmenler KN
    Asia Pac Psychiatry; 2020 Dec; 12(4):e12415. PubMed ID: 32827247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients.
    Rizos EN; Papathanasiou M; Michalopoulou PG; Mazioti A; Douzenis A; Kastania A; Nikolaidou P; Laskos E; Vasilopoulou K; Lykouras L
    Schizophr Res; 2011 Jul; 129(2-3):201-4. PubMed ID: 21470828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.
    Pillai A; Kale A; Joshi S; Naphade N; Raju MS; Nasrallah H; Mahadik SP
    Int J Neuropsychopharmacol; 2010 May; 13(4):535-9. PubMed ID: 19941699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study.
    Singh J; Verma R; Raghav R; Sarkar S; Sood M; Jain R
    Asian J Psychiatr; 2020 Dec; 54():102370. PubMed ID: 33271690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.
    Sotiropoulou M; Mantas C; Bozidis P; Marselos M; Mavreas V; Hyphantis T; Antoniou K
    Life Sci; 2013 Mar; 92(4-5):305-10. PubMed ID: 23333821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia.
    Weickert CS; Lee CH; Lenroot RK; Bruggemann J; Galletly C; Liu D; Balzan R; Pillai A; Buckley P; Weickert TW
    Schizophr Res; 2019 Jul; 209():212-217. PubMed ID: 31088701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis.
    Ruiz de Azua S; Matute C; Stertz L; Mosquera F; Palomino A; de la Rosa I; Barbeito S; Vega P; Kapczinski F; González-Pinto A
    BMC Psychiatry; 2013 Jan; 13():27. PubMed ID: 23320462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
    Martinotti G; Di Iorio G; Marini S; Ricci V; De Berardis D; Di Giannantonio M
    J Biol Regul Homeost Agents; 2012; 26(3):347-56. PubMed ID: 23034254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics.
    González-Pinto A; Mosquera F; Palomino A; Alberich S; Gutiérrez A; Haidar K; Vega P; Barbeito S; Ortiz A; Matute C
    Int Clin Psychopharmacol; 2010 Jul; 25(4):241-5. PubMed ID: 20568658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein levels of brain-derived neurotrophic factor pathways and their association with cognitive performance in patients with clinical high risk for psychosis and first episode psychosis.
    He Y; Yuan L; Li Z; Zhou Y; Ma X; Ouyang L; Chen X
    Schizophr Res; 2019 Apr; 206():460-461. PubMed ID: 30503369
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
    Rizos EN; Michalopoulou PG; Siafakas N; Stefanis N; Douzenis A; Rontos I; Laskos E; Kastania A; Zoumpourlis V; Lykouras L
    Neuropsychobiology; 2010; 62(2):87-90. PubMed ID: 20523079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum brain-derived neurotrophic factor levels and psychotic symptoms in heroin dependence.
    Han B; Zhang XY; Wang DY; Ren WW; Gu YY; Zhu L; Chang YL; Wang LP; Wu CW; Jin QQ; Chen C; Lyu DZ; Zhao JY; Shao B; He JC
    Compr Psychiatry; 2015 Oct; 62():80-5. PubMed ID: 26343470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
    Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.